bendamustine hydrochloride has been researched along with Cholangiocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, F; Caca, K; Hennig, L; Merkle, K; Preiss, R; Sohr, R; Teichert, J | 1 |
| Bailey, B; Baumann, F; Caca, K; Chao, Q; Franklin, C; Hennig, L; Patzak, U; Preiss, R; Schoppmeyer, K; Teichert, J | 1 |
2 other study(ies) available for bendamustine hydrochloride and Cholangiocarcinoma
| Article | Year |
|---|---|
Synthesis and characterization of some new phase II metabolites of the alkylator bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinoma.
Topics: Bendamustine Hydrochloride; Bile; Cholangiocarcinoma; Chromatography, High Pressure Liquid; Humans; Nitrogen Mustard Compounds; Spectrometry, Mass, Electrospray Ionization | 2005 |
Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
Topics: Aged; Bendamustine Hydrochloride; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line; Cholangiocarcinoma; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Female; Humans; Male; Microsomes, Liver; Nitrogen Mustard Compounds; Reference Standards | 2007 |